Pre-market Hot Trades in US Stocks
Algorhythm is down 8.47% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 18, Algorhythm Holdings announced an expanded contract with Procter &amp; Gamble India, increasing the annual contract value by 32% to $4.2 million. Although this news is favorable for the company's long-term development, market concerns about short-term profitability led to a decline in stock price.
</li>
<li>
On May 18, the company issued a forward-looking statement mentioning management's expectations and risk factors for the future. Investor concerns about these risk factors may have exacerbated stock price volatility.
</li>
<li>
On May 19, the unemployment rate fell to 4.5%, and the overall stock market rose by 2%. Despite the improvement in the macroeconomic environment, Algorhythm's stock price failed to benefit, indicating specific concerns in the market regarding this stock. The macroeconomic improvement and overall market rise were noted.
</li>
</ol>
Coreweave is down 3.87% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 19, DA Davidson downgraded CoreWeave's rating to neutral and lowered the target price to $100, leading to a significant drop in stock price. Analysts pointed out that low margins, rising costs, and reliance on debt are major risks. Source: Zhitong Finance
</li>
<li>
On May 16, CoreWeave's Chief Strategy Officer sold 63,539 shares of Class A common stock at prices between $106.99 and $112.73, potentially raising market concerns about insider confidence. Source: EDGAR
</li>
<li>
On May 18, NVIDIA increased its stake in CoreWeave to 47.2 million shares, raising its ownership percentage to 11%, showing confidence in the company's long-term development. Source: SEC announcement AI infrastructure attracts attention, with significant capital inflows.
</li>
</ol>
Top Gainers in Pre-market US Stocks
Amesite is up 224.39% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 19, Amesite announced an agreement with a new enterprise client involving approximately 2,700 patients, marking its largest deployment to date, which significantly boosted the stock price in pre-market trading. This client will use the NurseMagic AI documentation tool to streamline workflows, expected to significantly reduce the administrative burden on nurses weekly. This move is seen as a major validation of its corporate strategy, leading to a 250% stock price increase. Source: Zhitong Finance
</li>
<li>
On May 19, Amesite's CEO Ann Marie Sastry and director George Parmer purchased large amounts of company stock and warrants, showing confidence in the company's future, further driving up the stock price. Source: Zhitong Finance
</li>
<li>
On May 19, Amesite reported revenue growth to $285,678, with net losses narrowing to $2.05 million. Despite successfully raising $2.6 million in funding and strategically shifting towards medical AI solutions, there remain significant doubts about its ability to continue as a going concern
Source: Zhitong Finance AI The medical industry is growing rapidly, with significant capital inflow.
</li>
</ol>
Meiwutec rose 111.41% in pre-market trading, with no important news recently. The trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.
MetaVia rose 63.96% in pre-market trading. MetaVia rose 63.96% in pre-market trading. There is no important news recently; the trading is active, and the capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. no_news

RIME

CRWV

Algorhythm pre-market down 8.47%; Coreweave pre-market down 3.87%; Amesite pre-market up 224.39%; Meitu Technology pre-market up 111.41%; MetaVia pre-market up 63.96%

Price Alert

Algorhythm

Pre-market hot trades in US stocks: Algorhythm pre-market down 8.47%; Coreweave pre-market down 3.87%